BioSTL
Overview
A St. Louis-based non-profit organization founded in 2001 to build the region's innovation economy with a focus on medical and plant biosciences. It operates a comprehensive set of programs including startup creation and investment through its arm, BioGenerator, which is one of the most active early-stage biotech investors in the U.S. BioSTL also engages in strategic business attraction (GlobalSTL), physical environment development, and public policy advocacy.
Portfolio Companies
3
Website
biostl.orgInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Geneoscopy | Nov 2021 | Series B | - |
| Apolo Biotech | Oct 2025 | Grant | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is BioSTL based?
BioSTL is headquartered in St. Louis, Missouri, United States.
When was BioSTL founded?
Founding year information for BioSTL is not publicly available.
How many portfolio companies does BioSTL have?
BioSTL has 3 portfolio companies in Caplight's dataset.
What are some companies in BioSTL's portfolio?
Portfolio companies visible on Caplight include Geneoscopy, Apolo Biotech.
What was BioSTL's most recent investment shown here?
BioSTL's most recent investment in this portfolio sample was in Apolo Biotech in 2025.
What sectors does BioSTL focus on?
BioSTL focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Energy & Sustainability, Healthcare & Life Sciences.
What company stages does BioSTL focus on?
BioSTL typically invests at the Mid stage.